Creative Biolabs-Immuno-oncology

Anti-CD44 v6/v7 (clone RG7J35L6Z) SynExpress trc-YF-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR1603)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44 v6/v7 (clone RG7J35L6Z). We employs the AAV (trc-YFP-c-Jun-KpnI) vector components and the SynExpress system of the Exons Inversion/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CD44 v6/v7
Clone
RG7J35L6Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
trc
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
AAV
Transformation Accuracy
0.87
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving